Canget BioTekpharma is a biotech and biopharma company, which was spun off from Roswell Park Cancer Institute (RPCI, Buffalo, New York) and focuses on development of novel, cancer-targeting anticancer agents. The firm aims to improve patient survival time and/or survival rate through controlling cancer cell drug resistance and tumor relapse by providing low toxic and cancer-targeting anticancer agents for patients. The company's drug pipeline contains 10 varius drugs treating head, neck, colon, prostate, ovarian, and lung cancer as well as mesothelioma. The firm colloborates with insitutions such as Ocean University of China, Research Triangle Institute, Shandong University School of Pharmaceutical Sciences, and State University of New York (SUNY) at Buffalo.
